Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design

Detalhes bibliográficos
Autor(a) principal: Shahba, Ahmad Abdul-Wahhab
Data de Publicação: 2016
Outros Autores: Mohsin, Kazi, Alanazi, Fars Kaed, Abdel-Rahman, Sayed Ibrahim
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/128381
Resumo: Formulators face great challenges in adopting systematic approaches for designing self-nanoemulsifying formulations (SNEFs) for different drug categories. In this study, we aimed to build-up an advanced SNEF development framework for weakly basic lipophilic drugs, such as cinnarizine (CN). First, the influence of formulation acidification on CN solubility was investigated. Second, formulation self-emulsification in media with different pH was assessed. Experimentally designed phase diagrams were also utilized for advanced optimization of CN-SNEF. Finally, the optimized formulation was examined using cross polarizing light microscopy for the presence of liquid crystals. CN solubility was significantly enhanced upon external and internal acidification. Among the various fatty acids, oleic acid-based formulations showed superior self-emulsification in all the tested media. Surprisingly, formulation turbidity and droplet size significantly decreased upon equilibration with CN. The design was validated using oleic acid/Imwitor308/Cremophor El (25/25/50), which showed excellent self-nanoemulsification, 43-nm droplet size (for CN-equilibrated formulations), and 88 mg/g CN solubility. In contrast to CN-free formulations, CN-loaded SNEF presented lamellar liquid crystals upon 50% aqueous dilution. These findings confirmed that CN-SNEF efficiency was greatly enhanced upon drug incorporation. The adopted strategy offers fast and accurate development of SNEFs and could be extrapolated for other weakly basic lipophilic drugs.
id USP-31_e43803d8a24016cdce27ea9427d7599f
oai_identifier_str oai:revistas.usp.br:article/128381
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental designFormulators face great challenges in adopting systematic approaches for designing self-nanoemulsifying formulations (SNEFs) for different drug categories. In this study, we aimed to build-up an advanced SNEF development framework for weakly basic lipophilic drugs, such as cinnarizine (CN). First, the influence of formulation acidification on CN solubility was investigated. Second, formulation self-emulsification in media with different pH was assessed. Experimentally designed phase diagrams were also utilized for advanced optimization of CN-SNEF. Finally, the optimized formulation was examined using cross polarizing light microscopy for the presence of liquid crystals. CN solubility was significantly enhanced upon external and internal acidification. Among the various fatty acids, oleic acid-based formulations showed superior self-emulsification in all the tested media. Surprisingly, formulation turbidity and droplet size significantly decreased upon equilibration with CN. The design was validated using oleic acid/Imwitor308/Cremophor El (25/25/50), which showed excellent self-nanoemulsification, 43-nm droplet size (for CN-equilibrated formulations), and 88 mg/g CN solubility. In contrast to CN-free formulations, CN-loaded SNEF presented lamellar liquid crystals upon 50% aqueous dilution. These findings confirmed that CN-SNEF efficiency was greatly enhanced upon drug incorporation. The adopted strategy offers fast and accurate development of SNEFs and could be extrapolated for other weakly basic lipophilic drugs.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/12838110.1590/s1984-82502016000400009Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 653-667Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 653-667Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 653-6672175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/128381/125254Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessShahba, Ahmad Abdul-WahhabMohsin, KaziAlanazi, Fars KaedAbdel-Rahman, Sayed Ibrahim2017-03-16T18:09:44Zoai:revistas.usp.br:article/128381Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2017-03-16T18:09:44Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
title Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
spellingShingle Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
Shahba, Ahmad Abdul-Wahhab
title_short Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
title_full Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
title_fullStr Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
title_full_unstemmed Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
title_sort Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
author Shahba, Ahmad Abdul-Wahhab
author_facet Shahba, Ahmad Abdul-Wahhab
Mohsin, Kazi
Alanazi, Fars Kaed
Abdel-Rahman, Sayed Ibrahim
author_role author
author2 Mohsin, Kazi
Alanazi, Fars Kaed
Abdel-Rahman, Sayed Ibrahim
author2_role author
author
author
dc.contributor.author.fl_str_mv Shahba, Ahmad Abdul-Wahhab
Mohsin, Kazi
Alanazi, Fars Kaed
Abdel-Rahman, Sayed Ibrahim
description Formulators face great challenges in adopting systematic approaches for designing self-nanoemulsifying formulations (SNEFs) for different drug categories. In this study, we aimed to build-up an advanced SNEF development framework for weakly basic lipophilic drugs, such as cinnarizine (CN). First, the influence of formulation acidification on CN solubility was investigated. Second, formulation self-emulsification in media with different pH was assessed. Experimentally designed phase diagrams were also utilized for advanced optimization of CN-SNEF. Finally, the optimized formulation was examined using cross polarizing light microscopy for the presence of liquid crystals. CN solubility was significantly enhanced upon external and internal acidification. Among the various fatty acids, oleic acid-based formulations showed superior self-emulsification in all the tested media. Surprisingly, formulation turbidity and droplet size significantly decreased upon equilibration with CN. The design was validated using oleic acid/Imwitor308/Cremophor El (25/25/50), which showed excellent self-nanoemulsification, 43-nm droplet size (for CN-equilibrated formulations), and 88 mg/g CN solubility. In contrast to CN-free formulations, CN-loaded SNEF presented lamellar liquid crystals upon 50% aqueous dilution. These findings confirmed that CN-SNEF efficiency was greatly enhanced upon drug incorporation. The adopted strategy offers fast and accurate development of SNEFs and could be extrapolated for other weakly basic lipophilic drugs.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/128381
10.1590/s1984-82502016000400009
url https://www.revistas.usp.br/bjps/article/view/128381
identifier_str_mv 10.1590/s1984-82502016000400009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/128381/125254
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 653-667
Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 653-667
Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 653-667
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222912864583680